Seedlabs

Individualized A1C Goal Engine for EHRs

A tool that sets a personal blood sugar goal for each patient and warns doctors of over-treatment.

A tool that calculates each patient's personal A1C target from their chart per current ADA guidance, stores it as a discrete EHR field, and warns clinicians when treatment is being pushed below that personal goal (overtreatment) or left sitting above it.

MedicineDiabetes Management and Research
Attention Deficit Hyperactivity DisorderHealth-system EHR clinical decision support for diabetes treatment goals

Concept

An EHR-embedded module that, for every patient with diabetes, computes a personal A1C target from structured chart data — age, comorbidities and life-expectancy proxies, history and risk of hypoglycemia, diabetes duration, current regimen and A1C — according to the ADA's current glycemic-goals recommendations [0], and writes it to a discrete, visible field on the chart and patient portal. Two point-of-care alerts hang off that field:

  1. Overtreatment guard — fires when a clinician orders therapy intensification (a new agent or dose increase) while the patient is already at or below their individualized goal, with a one-click acknowledgment that the goal is already met.
  2. Persistent-gap prompt — fires when repeated A1C results sit above the individualized goal with no documented regimen change, nudging intensification along the pharmacologic standards [1].

The goal recomputes as the chart changes and is re-validated against each annual Standards edition.

Why now

The 2026 ADA Standards chapter on glycemic goals [0] is the profession's current, annually refreshed statement of diabetes treatment goals, built around individualizing targets to the patient rather than applying one number to everyone. Yet most EHRs hold no discrete patient-level goal field, so above-goal alerts default to a single threshold — under-treating some patients and, more dangerously, pushing older or frail patients into hypoglycemia-prone overtreatment. The companion pharmacologic chapter [1] defines the intensification pathway, giving the engine a precise intervention point: the intensification order. Because the Standards are revised annually by an interprofessional expert committee with an evidence-grading system [0], goal logic must be maintained against the live edition — the recurring reason to subscribe rather than build once.

Written by GLM · 11 Oct 2026

AI assessment

Backed by 2 papers86

A highly focused, evidence-backed clinical decision support tool that solves a specific safety and quality gap in diabetes management by operationalizing ADA guidelines.

Evidence strength
5/5
The idea directly maps to the 2026 ADA Standards on Glycemic Goals and Pharmacologic Approaches, which provide the exact logic needed for the engine.
Market pull
4/5
Large health systems (Kaiser, Geisinger) have strong incentives to reduce hypoglycemia-related admissions and improve quality metrics for diabetes care.
Novelty & moat
3/5
While it shares a theme with the 'Standards-of-Care Diff Feed,' it moves from a general update service to a specific, functional clinical tool with a distinct mechanism.
Feasibility
4/5
The logic is deterministic based on structured EHR data (age, labs, comorbidities), making the MVP technically straightforward to build as an API or module.
Wedge clarity
5/5
The 'overtreatment guard' is a sharp, high-value entry point that addresses a critical patient safety risk (hypoglycemia in frail patients).
Simplicity / focus
5/5
The product is a single, well-defined utility—calculating a target and firing two specific alerts—avoiding platform bloat.

Scored by Gemma 4 · 11 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • One of the largest diabetes populations in U.S. integrated care, on a single EHR that can hold a discrete individualized-goal field; the engine directly reduces hypoglycemia-prone overtreatment in older members, a known quality and cost harm.

  • Geisingercompany

    A health system known for data-driven diabetes care-gap programs; the goal engine extends their gap analytics from above-goal to wrong-goal-for-this-patient, sharpening existing outreach work.

  • The dominant EHR vendor could ship the goal engine as a native diabetes decision-support feature, differentiating its clinical content for thousands of health-system customers.

  • Its clinical guidance cautions against intensive glycemic targets in older adults; a tool that operationalizes individualized goals inside the EHR turns that position into routine practice.

Research it builds on

  1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026
    Mandeep Singh Bajaj, Rozalina Grubina McCoy, Kirthikaa Balapattabi et al. · 2025 · 191 citations
    All ideas from this paper →
  2. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026
    Mandeep Singh Bajaj, Rozalina Grubina McCoy, Kirthikaa Balapattabi et al. · 2025 · 136 citations
    All ideas from this paper →
Leave feedback
feasibility